Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 826 of 5804
-
Experimental combo aims to reboot immune system against Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to assess the feasibility, safety, and efficacy of anti-PD-1 antibody alone or in combination with low-dose decitabine in patients with relapsed or refractory malignancies, including Non-Hodgkin'lymphoma, Hodgkin'lymphoma, gastrointestinal cancers, he…
Phase: PHASE1, PHASE2 • Sponsor: Han weidong • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Breath analysis may sniff out lung cancer
Diagnosis CompletedTo answer the question whether a disease specific profile of breath in patients with lung cancer can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.
Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Nurse Check-Ins after suicide attempt show promise in preventing repeat crisis
Prevention CompletedTo evaluate the impact of a specific nursing management (personalized and close, through consultation at the hospital, at home or by phone) monitoring in post-hospitalization, the suicide attempt of recurrence and suicidal crisis, in the year following a suicide attempt in patien…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
New drug cocktail aims to keep myeloma at bay after transplant
Disease control OngoingThis is a Phase 3 randomized trial of carfilzomib, lenalidomide, dexamethasone versus lenalidomide alone after stem-cell transplant for multiple myeloma, eligible to subjects who completed autologous stem cell transplant for symptomatic myeloma who are considered for lenalidomide…
Phase: PHASE3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Could a Pacemaker-Like device ease heart failure?
Disease control CompletedThe purpose of this clinical trial (NCT02627196) is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therapy with the BAROSTIM NEO System in subjects with heart failure, defined as New York Heart Association (NYHA) functional Class III, l…
Phase: NA • Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Gene-Tailored therapy shows promise for aggressive breast cancer
Knowledge-focused OngoingBreast cancer is an optimal "model disease" for studying personalized medicine. Breast cancer was the first malignancy for which a predictive factor forecasting response to therapy was identified nearly 50 years ago; the expression of the estrogen receptor (ER). Furthermore, brea…
Phase: PHASE2 • Sponsor: Haukeland University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can a daily aspirin help fight colorectal cancer? new trial targets genetic weakness
Disease control OngoingALASCCA is a randomized, parallel group, double blind, multicenter, placebo-controlled, biomarker-based study of adjuvant treatment with low dose aspirin in patients with colorectal cancer. Hypothesis is that patients diagnosed with colorectal cancer and somatic mutations in PI3K…
Phase: PHASE3 • Sponsor: Anna Martling • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New triple inhaler shows promise for uncontrolled asthma
Disease control CompletedEvaluate the superiority of CHF 5993 200/6/12.5 µg pressurised metered dose inhaler (pMDI) (fixed combination of extrafine beclometasone dipropionate plus formoterol fumarate plus glycopyrronium bromide) versus CHF 1535 200/6 µg pMDI (fixed combination of extrafine beclometasone …
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New study tests if proton therapy spares hearts in breast cancer patients
Disease control OngoingA pragmatic randomized clinical trial of patients with locally advanced breast cancer randomized to either proton or photon therapy and followed longitudinally for cardiovascular morbidity and mortality, health-related quality of life, and cancer control outcomes. Quality of life…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New staged treatment shows promise for preventing psychosis in At-Risk youth
Disease control CompletedA sequential multistage randomised clinical trial (SMART) to produce evidence to guide a step-wise clinical approach for the treatment of ultra high risk patients and reduction of risk for psychosis and other deleterious clinical and/or functional outcomes.
Phase: PHASE3 • Sponsor: Orygen • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New proton beam combo aims to shrink pancreatic tumors for surgery
Disease control Recruiting nowThe prognosis for patients with localized pancreatic adenocarcinoma who are not surgical candidates is poor. Patients characterized as having "borderline resectable" disease treated with preoperative chemo-radiotherapy fair somewhat better - although many of these patients are no…
Phase: PHASE2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 26, 2026 14:24 UTC
-
Gene therapy shot aimed at diabetic nerve pain put to the test
Symptom relief CompletedThe purpose of this study is to determine the safety and efficacy of bilateral intramuscular injections of VM202 versus placebo in the treatment of painful diabetic peripheral neuropathy. A total of 507 of 477 planned participants were randomized in a 2:1 ratio to one of two tre…
Phase: PHASE3 • Sponsor: Helixmith Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Lung cancer drug cocktail shows promise in delaying tumor growth
Disease control CompletedThis is a randomized, open-label, controlled, multicenter, Phase III study. Patients will be randomly assigned to treatment group (1:1) through a dynamic randomization process with use of the following stratification factors: sex (female/male), disease stage (stage IIIb vs. stage…
Phase: PHASE3 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Jail-to-Community suicide prevention: a simple plan could save lives
Disease control CompletedThe four year SPIRIT Trial, or Suicide Prevention Intervention for at-Risk Individuals in Transition, will recruit 800 pretrial jail detainees at risk for suicide. Each participant will be randomly assigned to today's standard care or to Safety Planning Intervention (SPI) method …
Phase: NA • Sponsor: Michigan State University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New immunotherapy cocktails aim to boost pancreatic cancer surgery success
Disease control OngoingThis platform trial will evaluate various immunotherapy combinations given in the neo-adjuvant and adjuvant setting in patients with surgically resectable pancreatic ductal adenocarcinoma.
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo may outperform chemo for returning ovarian cancer
Disease control OngoingThis phase III trial studies olaparib or cediranib maleate and olaparib to see how well they work compared with standard platinum-based chemotherapy in treating patients with platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer that has come back. Olaparib and…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo aims to wipe out rectal tumors before surgery
Disease control OngoingThe purpose of this study is to see how effective and safe LY2157299, in combination with chemotherapy and radiation therapy, might be in treating rectal cancer. Also as part of this study, research will be done on tumor samples to see if it is possible to predict if patients wil…
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug cocktail shows promise for leukemia patients
Disease control OngoingThis phase II trial studies how well ibrutinib, fludarabine phosphate, cyclophosphamide, and obinutuzumab work in treating patients with chronic lymphocytic leukemia. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used …
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New drug cocktail shows promise for tough cancers
Disease control OngoingThe purpose of this study is to look at the effectiveness, safety, and antitumor activity of study drugs MEDI4736 in combination with olaparib (modules 1, 2, 3, 4, 5 and 7) and MEDI4736 in combination with olaparib and bevacizumab (module 6). It will also examine what happens to …
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Half-Matched stem cell transplant offers hope for blood cancer patients
Disease control Recruiting nowNow haplo stem cell transplant using bone marrow or peripheral blood is becoming more feasible with better regimens to prevent graft versus host disease (GVHD) like post transplant cyclophosphamide , tacrolimus, mycophenolate . Recently Bortezomib has also been shown to inhibit d…
Phase: PHASE2 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC